| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000225725.4 |
Ponatinib |
Colon adenocarcinoma |
0.039862177 |
Resistant |
| ENSG00000225725.4 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011606846 |
Resistant |
| ENSG00000225725.4 |
Ponatinib |
Bladder urothelial carcinoma |
0.028667086 |
Sensitive |
